Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Induces of periodontitis increases salivary orosomucoid levels

Figen Ongoz Dede, Ceren Gokmenoglu, Ismail Onur Sahin.




Abstract
Cited by 1 Articles

Aim: Periodontitis is characterized by chronic infection and inflammation in periodontal tissues leading to destruction of dental support tissues. Acute-phase proteins are effective markers for the identification and evaluation of inflammatory diseases including periodontitis. Orosomucoid (ORM) is an acute-phase plasma protein, also called alpha-1-acid glycoprotein, which is inflammation sensitive. The aim of this study was to evaluate and compare the salivary levels of ORM and C-reactive protein (CRP) in individuals with/withoutperiodontal disease.
Material and Methods: A total of 90 subjects were divided into two groups of 45 patients each; periodontally healthy and chronic periodontitis. Saliva samples were collected, and clinical periodontal parameters and salivary flow rates were evaluated at baseline. The ORM and CRP levels in the saliva were analyzed with enzyme-linked immunosorbent assay.
Results: The periodontal clinical parameters were significantly higher in the chronic periodontitis group when compared to those of the healthy controls (P0.05). However, the CRP and ORM levels in the saliva were significantly higher in the chronic periodontitis patients than in the healthy controls (P

Key words: Acute-Phase Protein; Orosomucoid; Periodontitis; Saliva.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.